What is the recommended treatment approach for allergic rhinitis, chronic urticaria, and allergic asthma?

Treatment Approach for Allergic Diseases

Allergic Rhinitis

For persistent allergic rhinitis, use continuous second-generation antihistamines or intranasal corticosteroids (INCS), with fixed-combination intranasal antihistamine plus corticosteroid (INAH+INCS) preferred over either agent alone for moderate-to-severe symptoms. 1, 2

Treatment Algorithm by Severity and Pattern

Mild Persistent Symptoms:

• Initiate continuous second-generation oral antihistamines (cetirizine, loratadine, desloratadine, fexofenadine, or levocetirizine) rather than intermittent use due to ongoing allergen exposure 1, 3
• Cetirizine has the fastest onset of action when rapid relief is needed 4
• Second-generation agents are strongly preferred over first-generation antihistamines due to superior safety profile, minimal sedation, and lack of cognitive impairment 1, 5

Moderate-to-Severe Persistent Symptoms:

• Start with INCS (fluticasone, triamcinolone, budesonide, or mometasone) as monotherapy, or preferably use fixed-combination INAH+INCS (such as azelastine/fluticasone) which is superior to either component alone 3, 2
• The combination provides faster symptom relief and addresses both histamine-mediated and inflammatory pathways 2

Intermittent/Episodic Symptoms:

• Use second-generation antihistamines on an as-needed basis due to their relatively rapid onset of action 1
• Intranasal antihistamines (azelastine, olopatadine) can be used as monotherapy for mild intermittent disease 3

Critical Pitfalls to Avoid

• Never use intranasal decongestants continuously beyond 3-7 days due to risk of rhinitis medicamentosa 1
• Avoid first-generation antihistamines (diphenhydramine, hydroxyzine) as they cause significant sedation, cognitive impairment, and have been associated with accidents and cardiac death 5
• For inadequate response to pharmacologic therapy, refer for allergen immunotherapy rather than continuing indefinite antihistamine escalation 1

Special Populations

• Patients with both AR and asthma benefit from prolonged antihistamine therapy with agents like levocetirizine, which reduces comorbidities and improves quality of life 1
• Periodic reassessment is essential for patients on long-term therapy to evaluate symptom control, adherence, side effects, and need for treatment adjustment 1

---

Chronic Urticaria

For chronic urticaria, initiate non-sedating second-generation H1-antihistamines at standard doses, then updose up to 4-fold if inadequate control is achieved, followed by omalizumab 300 mg subcutaneously every 4 weeks for refractory cases. 4, 6

Stepwise Treatment Algorithm

First-Line Treatment:

• Start with second-generation H1-antihistamines (cetirizine, desloratadine, fexofenadine, levocetirizine, or loratadine) at standard doses 4, 7
• Use these agents regularly (not as-needed) for optimal control 7
• Cetirizine provides the fastest onset when rapid relief is needed 4

Second-Line (Inadequate Response):

• Increase the antihistamine dose up to 4 times the standard dose when potential benefits outweigh risks 4, 6
• Example: cetirizine can be increased from 10 mg daily to 40 mg daily 6
• This approach is effective in approximately 50% of patients who don't respond to standard dosing 6

Third-Line (Antihistamine-Refractory):

• Add omalizumab 300 mg subcutaneously every 4 weeks, which is effective in 70% of antihistamine-refractory patients 4, 6
• Omalizumab dosing can be adjusted by shortening intervals or increasing dosage if necessary 8

Fourth-Line (Omalizumab-Refractory):

• Consider cyclosporine, which is effective in 65-70% of patients unresponsive to antihistamines and omalizumab 6
• Monitor blood pressure and renal function carefully due to potential side effects 6

Adjunctive Measures

• Identify and avoid trigger factors including overheating, stress, alcohol, aspirin, NSAIDs, and codeine in sensitive patients 4
• Cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) provide symptomatic relief 4
• For nighttime pruritus interfering with sleep, short-term intermittent use of sedating antihistamines like hydroxyzine may be beneficial, but should not substitute for primary therapy 8

What NOT to Do

• Avoid chronic systemic corticosteroids due to cumulative toxicity; reserve brief 3-10 day courses only for severe exacerbations 6
• Corticosteroids are not useful in acute urticaria but may be used empirically to prevent biphasic reactions 4
• H2-receptor blockers and leukotriene antagonists are no longer recommended as they add little efficacy 6

Special Populations

• Renal insufficiency: Avoid acrivastine; reduce cetirizine, levocetirizine, and hydroxyzine doses by half 4
• Hepatic insufficiency: Avoid mizolastine 4
• Pregnancy: Avoid antihistamines if possible, especially in first trimester; if necessary, choose chlorpheniramine due to long safety record 4

Prognosis

• Approximately 50% of patients with chronic urticaria presenting with only hives will be symptom-free at 6 months 4
• Patients with both hives and angioedema have poorer prognosis, with >50% still having active disease after 5 years 4

---

Allergic Asthma

For allergic asthma, H1-antihistamines serve as adjunctive therapy for secondary allergic symptoms but are not primary asthma controllers; focus on inhaled corticosteroids and bronchodilators as mainstay treatment. 7

Role of Antihistamines

• Antihistamines can provide comfort for secondary allergic symptoms in patients with allergic asthma, depending on the individual 7
• They address the allergic rhinitis component that frequently coexists with asthma 1
• Prolonged antihistamine therapy in patients with both AR and asthma reduces comorbidities and improves rhinitis-specific quality of life 1

Integration with Asthma Management

• Antihistamines complement but do not replace standard asthma controllers (inhaled corticosteroids, long-acting beta-agonists) 7
• Optimizing allergic rhinitis control with antihistamines may improve overall asthma outcomes in patients with both conditions 1

---

Anaphylaxis Recognition and Management

Immediate intramuscular epinephrine is the only definitive treatment for anaphylaxis; antihistamines are purely adjunctive for symptomatic relief of pruritus and urticaria and never substitute for epinephrine. 4

Signs Requiring Immediate Epinephrine

• Respiratory compromise: stridor, difficulty breathing, wheezing, laryngeal edema 4
• Cardiovascular compromise: hypotension, tachycardia, weak/absent pulse, syncope 4
• Angioedema affecting mouth, tongue, or throat 4

Epinephrine Dosing

• Children <25 kg: 0.15 mg intramuscular 4
• Children >25 kg and adults: 0.3 mg intramuscular 4
• Alternative dosing: 0.01 mg/kg (maximum 0.5 mg) of 1:1,000 solution 4

Adjunctive Role of Antihistamines

• H1-antihistamines (diphenhydramine 25-50 mg) are useful only for relieving pruritus and urticaria, not for treating the life-threatening components of anaphylaxis 4
• Corticosteroids are not useful in acute anaphylaxis but may be used empirically to prevent biphasic reactions that occur in up to 20% of cases 4